NZ334101A - Neuraminic acid derivatives and use in treating viral infections - Google Patents

Neuraminic acid derivatives and use in treating viral infections

Info

Publication number
NZ334101A
NZ334101A NZ334101A NZ33410197A NZ334101A NZ 334101 A NZ334101 A NZ 334101A NZ 334101 A NZ334101 A NZ 334101A NZ 33410197 A NZ33410197 A NZ 33410197A NZ 334101 A NZ334101 A NZ 334101A
Authority
NZ
New Zealand
Prior art keywords
compound
acceptable salt
hydrogen atom
doc
pharmacologically acceptable
Prior art date
Application number
NZ334101A
Other languages
English (en)
Inventor
Takeshi Honda
Yoshiyuki Kobayashi
Makoto Yamashita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NZ334101A publication Critical patent/NZ334101A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NZ334101A 1996-08-13 1997-08-12 Neuraminic acid derivatives and use in treating viral infections NZ334101A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21345696 1996-08-13
PCT/JP1997/002810 WO1998006712A1 (en) 1996-08-13 1997-08-12 Neuraminic acid compounds

Publications (1)

Publication Number Publication Date
NZ334101A true NZ334101A (en) 2001-07-27

Family

ID=16639524

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ334101A NZ334101A (en) 1996-08-13 1997-08-12 Neuraminic acid derivatives and use in treating viral infections

Country Status (17)

Country Link
EP (1) EP0934939B1 (enExample)
KR (1) KR100526666B1 (enExample)
CN (1) CN1126752C (enExample)
AT (1) ATE239006T1 (enExample)
AU (1) AU723994B2 (enExample)
CA (1) CA2263336C (enExample)
CZ (1) CZ293041B6 (enExample)
DE (1) DE69721553T2 (enExample)
DK (1) DK0934939T3 (enExample)
ES (1) ES2198002T3 (enExample)
HU (1) HU226130B1 (enExample)
IL (1) IL128358A (enExample)
NO (1) NO319321B1 (enExample)
NZ (1) NZ334101A (enExample)
PT (1) PT934939E (enExample)
RU (1) RU2169145C2 (enExample)
WO (1) WO1998006712A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002076980A1 (en) * 2001-03-27 2002-10-03 Sankyo Company, Limited Sialic acid derivatives
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
ATE399779T1 (de) * 2001-09-07 2008-07-15 Biota Scient Management Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
TWI546306B (zh) * 2007-04-11 2016-08-21 第一三共股份有限公司 神經胺酸衍生物之製造方法
CN102532080A (zh) * 2010-12-29 2012-07-04 中国科学院上海药物研究所 新型唾液酸衍生物及其制备方法,包含该衍生物的药物组合物,以及其用途
EP2678324A1 (en) * 2011-02-24 2014-01-01 Cadila Healthcare Limited Process for the preparation of zanamivir
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
CN117243852A (zh) * 2023-11-01 2023-12-19 华熙生物科技股份有限公司 一种皮肤外用组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2000786C1 (ru) * 1989-07-25 1993-10-15 Научно-исследовательский институт экспериментальной медицины РАМН Противовирусное средство при гриппозной инфекции
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
RU2032683C1 (ru) * 1991-07-02 1995-04-10 Андрейчиков Юрий Сергеевич 2-метил-5-метокси-3-метоксалилацетобензофуран, проявляющий противовирусную активность в отношении вируса гриппа типа а и в
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
RU2030412C1 (ru) * 1992-03-04 1995-03-10 Иркутский институт органической химии СО РАН Способ получения 2-формил-2,5- дибутилтио-2,3- дигидро-4h-пирана
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds

Also Published As

Publication number Publication date
AU723994B2 (en) 2000-09-07
DE69721553D1 (de) 2003-06-05
EP0934939A1 (en) 1999-08-11
RU2169145C2 (ru) 2001-06-20
KR100526666B1 (ko) 2005-11-08
NO990672D0 (no) 1999-02-12
CN1232461A (zh) 1999-10-20
CZ293041B6 (cs) 2004-01-14
WO1998006712A1 (en) 1998-02-19
CN1126752C (zh) 2003-11-05
IL128358A0 (en) 2000-01-31
DK0934939T3 (da) 2003-07-21
PT934939E (pt) 2003-07-31
HUP9903632A2 (hu) 2001-08-28
CZ36599A3 (cs) 1999-06-16
DE69721553T2 (de) 2004-07-22
ES2198002T3 (es) 2004-01-16
NO319321B1 (no) 2005-07-11
AU3785897A (en) 1998-03-06
EP0934939A4 (enExample) 1999-09-15
IL128358A (en) 2003-04-10
EP0934939B1 (en) 2003-05-02
CA2263336C (en) 2007-03-13
CA2263336A1 (en) 1998-02-19
KR20000029971A (ko) 2000-05-25
HK1022687A1 (en) 2000-08-18
ATE239006T1 (de) 2003-05-15
HU226130B1 (en) 2008-05-28
HUP9903632A3 (en) 2002-04-29
NO990672L (no) 1999-04-13

Similar Documents

Publication Publication Date Title
RU2124509C1 (ru) Производные нейраминовой кислоты, или их фармацевтически приемлемые соли, или их сложные эфиры, а также фармацевтическая композиция, обладающая сиалидазу-ингибирующей активностью
NZ334101A (en) Neuraminic acid derivatives and use in treating viral infections
US6844173B2 (en) Strain of Streptomyces griseus
JPWO1995032955A1 (ja) 7位をフッ素で置換した2,3−ジデヒドロシアル酸およびその合成中間体
JP3712158B2 (ja) ノイラミン酸化合物を含有する抗インフルエンザ薬
JP4151800B2 (ja) ノイラミン酸化合物
HK1022687B (en) Neuraminic acid compounds
MXPA99001527A (en) Neuraminic acid compounds
JP4428762B2 (ja) 抗生物質a−500359及び誘導体
JP5022539B2 (ja) 抗生物質a−500359及び誘導体を含有する抗菌剤
EP0318060B1 (en) Griseolic acid derivatives, their preparation and their use
EP0984018A1 (en) Derivatives of antifungal substance be-31405 and process for producing the same
JP2009256380A (ja) 抗生物質a−500359及び誘導体
JPS6345679B2 (enExample)
CZ20018A3 (cs) Nové antimikrobiální sloučeniny
JPWO1998052957A1 (ja) 抗真菌性物質be−31405誘導体及びその製造法

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: DAIICHI SANKYO COMPANY, LIMITED, JP

Free format text: OLD OWNER(S): SANKYO COMPANY LIMITED

RENW Renewal (renewal fees accepted)
EXPY Patent expired